Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.34 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ACE | P12821 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.30 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.30 |
| ▸ | TAS1R2 | Q8TE23 | 2/20 | 0.30 |
| ▸ | MME | P08473 | 1/20 | 0.30 |
| ▸ | CPA1 | P15085 | 1/20 | 0.30 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13778719 | 0.80 | — | — | |
| SCHEMBL4993792 | 0.75 | FOLH1 (0.37) | FOLH1NAALAD2ALDH1A1LMNAACE | |
| SCHEMBL2820334 | 0.75 | TAS1R3 (0.46) | FOLH1NAALAD2ALDH1A1LMNAMEN1 | |
| SCHEMBL20668082 | 0.69 | — | — | |
| SCHEMBL13951088 | 0.69 | ALDH1A1 (0.45) | FOLH1NAALAD2ALDH1A1LMNAMEN1 | |
| SCHEMBL745482 | 0.67 | ALDH1A1 (0.54) | FOLH1NAALAD2ALDH1A1LMNAMEN1 | |
| SCHEMBL6686267 | 0.65 | ALDH1A1 (0.45) | FOLH1NAALAD2ALDH1A1LMNAACE | |
| SCHEMBL1870979 | 0.65 | TP53 (0.39) | FOLH1NAALAD2ALDH1A1LMNAMEN1 | |
| SCHEMBL21568355 | 0.63 | TAS1R3 (0.42) | ALDH1A1TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL24408091 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1361246-B1 | ORGANIC POLYMER AND NOVEL POLYMERIZABLE COMPOUND | MITSUI CHEMICALS INC (JP) | 2009-02-18 | — | — | EP | disclosed |
| US-6797805-B2 | Organic polymers and novel polymerizable compounds | MITSUI CHEMICALS, INC. (JP) | 2004-09-28 | — | — | US | disclosed |
| EP-1361246-A1 | ORGANIC POLYMER AND NOVEL POLYMERIZABLE COMPOUND | Mitsui Chemicals, Inc. (JP) | 2003-11-12 | — | — | EP | disclosed |
| US-20030166808-A1 | Organic polymers and novel polymerizable compound | MITSUI CHEMICALS, INC. (JP) | 2003-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166808-A1 | Organic polymers and novel polymerizable compound | PCNA, UTP18, ODC1 | FOLH1 3523/4885NAALAD2 2943/4885ALDH1A1 4350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.